Senior Clinical Research Associate (Portuguese Speaking)

The George Institute for Global Health – UK Project Operations Team

Position Description

CAREER STEP: Intermediate

REPORTING RELATIONSHIP: Project Manager

TEAM: UK Project Operations, CORE

EMPLOYMENT DURATION: 2 years

TYPE OF EMPLOYMENT: Full-time

SALARY: 45-49k per annum

The George Institute for Global Health

We are a medical research institute affiliated with leading universities aiming to challenge the status quo in health care. With 700+ people around the world, and projects in over 40 countries, our Strategy 2025 is all about impact – specifically, the impact of The George Institute’s activities on the health of millions of people, particularly those living in disadvantaged circumstances around the world.

Our strategy focuses on three key research priorities:

• Better Treatments: finding better treatments for the world’s biggest health problems
• Better Care: transforming primary health care to support better health for more people
• Healthier Societies: harnessing the power of communities, governments, and markets to improve health

Our innovative commercial enterprises help maximise our impact.

Context of the Role

The Project Operations team in UK works closely with our Research teams globally to ensure study aims are achieved. The team is primarily responsible for the set-up, conduct and overall delivery of projects across all research programs in The Institute, according to best practice guidelines and research budgets.

The Role

The Senior Clinical Research Associate (SCRA) is required to assist the Project Manager with various tasks associated with running clinical studies. Generally, the SCRA performs all monitoring tasks required at study sites, including source data verification, safety reporting, drug accountability and the maintenance of study documentation. The SCRA provides regular study updates and monitoring visit reports to the Project Manager and updates clinical study tracking systems as necessary.

The SCRA may be required to travel frequently to Portugal including multiple day stays, as required to conduct on-site monitoring visits at investigative sites. This includes pre-study visits, site initiation visits, routine monitoring, and close-out visits, in accordance with the study protocol, Good Clinical Practice (GCP), and applicable regulatory requirements. The SCRA must be adaptable to changing travel schedules, capable of managing time effectively while on the road, and committed to maintaining a high standard of data quality and site support during all visits.

The SCRA is responsible for oversight and management of trial sites within Portugal and will be the main point of contact between the Portuguese sites and the trial team globally.

Reporting Relationships

The SCRA reports to a Project Manager within the UK Project Operations team. The SCRA will also develop effective working relationships with the study site staff and the Australian and India Project Operations team.

Duties and Key Responsibilities

Study Design

• Assist with the identification and selection of investigators/sites to undertake the study
• Conduct feasibility assessments

Study Execution

General

As a Team Member

Work, Health and Safety

Skills, Knowledge and Experience

Essential

• Academic Level (C1) written and spoken Portuguese or fluent Portuguese speaker
• Third-level qualifications in a related science or health care discipline
• Previous on-site monitoring experience working on clinical projects, particularly drug trials, within an academic, CRO or pharmaceutical environment

How to apply

Please provide a copy of your CV and an accompanying cover letter outlining why you think you'd be suitable for this role by clicking on the 'Apply' button above (e: recruitment@georgeinstitute.org.uk).

The deadline for applications is midnight on Wednesday 21 January 2026. If you have any questions, please email recruitment@georgeinstitute.org.uk.

Location:LondonSalary:£45,000 to £49,000 per annumHours:Full TimeContract Type:Fixed-Term/ContractPlaced On:7th January 2026Closes:21st January 2026